TrialAmerican journal of hematology2018

A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806.

Daniel O Persky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.